As states ease coronavirus restrictions, some are taking a 'significant risk,' Fauci says [CNN]
Gilead Sciences, Inc. (GILD)
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.gilead.com
Company Research
Source: CNN
As states ease coronavirus restrictions, some are taking a 'significant risk,' Fauci saysByFaith KarimiNicole ChavezUpdated 10:48 AM ET, Fri May 1, 2020Chat with us in Facebook Messenger. Find out what's happening in the world as it unfolds.JT WATCHEDReplay ...MT WATCH02:10(CNN)Coronavirus pandemic: Updates from around the worldThat warning comes as a team of pandemic experts predicted ina new reportCovid-19 has killed more than 63,000 people in the United States and infected over 1 million nationwide,according to Johns Hopkins University.Some governorsstarted loosening social distancing restrictionsBut some states are reopening without having metfederal guidelinesRead Critics said the flu kills more than coronavirus. Why that's not a fair comparison -- and now, it's not even trueThat could lead to a jump in cases and more deaths than predicted, health experts have said."There are some states, some cities ... kind of leapfrogging over the first checkpoint. And, I mean, obviously you
Show less
Read more
Impact Snapshot
Event Time:
GILD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GILD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
News
- Gilead Sciences: Why I'm Tempted To Sell Ahead Of Q1 Earnings - But Won't [Seeking Alpha]Seeking Alpha
- Arcus halts Gilead-partnered late-stage trial for lung cancer drug [Seeking Alpha]Seeking Alpha
- Citi Raises Gilead (GILD) Price Target Ahead of Q1 Biopharma Preview [Yahoo! Finance]Yahoo! Finance
- Jim Cramer on Gilead Sciences: “I'd Hold On to It” [Yahoo! Finance]Yahoo! Finance
- Gilead Sciences (GILD) had its price target raised by The Goldman Sachs Group, Inc. from $125.00 to $130.00. They now have a "neutral" rating on the stock.MarketBeat
GILD
Earnings
- 2/10/26 - Beat
GILD
Sec Filings
- 4/16/26 - Form 4
- 4/16/26 - Form 4
- 4/15/26 - Form 144
- GILD's page on the SEC website